Vaccine makers get boost from flu scare
May 21, 2009 at 13:20 PM EDT
Shares of niche makers of vaccines and anti-viral drugs have been on fire since the H1N1 flu first made headlines last month, but are these fledgling companies really in a position to cash in on a possible pandemic?
